[Disseminated Intravascular Coagulation Following Kidney Allotransplantation. Diagnostic Significance and Therapeutic Consequences]
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Zuhlke V, Holscher M, Pernice G Klin Wochenschr. 1975; 53(15):717-22.
PMID: 768629 DOI: 10.1007/BF01468703.
[Pathogenesis of uremic pneumonitis (author's transl)].
Bleyl U, Werner C, Busing C Klin Wochenschr. 1978; 56(3):121-34.
PMID: 628196 DOI: 10.1007/BF01478567.
References
1.
Fletcher A, ALKJAERSIG N, Sherry S
. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J Clin Invest. 1962; 41:896-916.
PMC: 290991.
DOI: 10.1172/JCI104546.
View
2.
Stiehm E, TRYGSTAD C
. Split products of fibrin in human renal disease. Am J Med. 1969; 46(5):774-86.
DOI: 10.1016/0002-9343(69)90028-x.
View
3.
Wardle E, Taylor G
. Fibrin breakdown products and fibrinolysis in renal disease. J Clin Pathol. 1968; 21(2):140-6.
PMC: 473708.
DOI: 10.1136/jcp.21.2.140.
View
4.
BUSCH G, Braun W, Carpenter C, Corson J, Galvanek E, Reynolds E
. Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc. 1969; 1(1):267-70.
View
5.
Koffler D, Paronetto F
. Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. II. Acute, subacute, and chronic glomerulonephritis. J Clin Invest. 1965; 44(10):1665-71.
PMC: 292651.
DOI: 10.1172/JCI105273.
View